Lymphoma, Leukemia & Myeloma Congress

Lymphoma, Leukemia & Myeloma Congress The premier forum for healthcare professionals who study and manage patients with lymphoma, myeloma

For the past sixteen years, L&M has been the premier forum on the latest advances in lymphoma and myeloma. Over forty internationally-recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. The Congress features an

interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphatic leukemia, lymphoma and Hodgkin’s disease.

September brings needed attention to blood cancers and the people affected by them. We stand with patients, loved ones, ...
09/10/2026

September brings needed attention to blood cancers and the people affected by them. We stand with patients, loved ones, and the hematology professionals working to move care forward.

Six weeks from today, hematology/oncology fellows from across the country will gather at the LL&M Congress Fellows Recep...
09/01/2026

Six weeks from today, hematology/oncology fellows from across the country will gather at the LL&M Congress Fellows Reception.

Join nationally recognized faculty and fellow trainees for an evening of meaningful conversation, mentorship, and new professional connections that can continue well beyond Congress.

Tuesday, October 13
7:00 PM
New York Marriott Marquis

Attendance is complimentary, but advance RSVP is requested: https://hubs.ly/Q04vNvHW0

Why attend the LL&M Congress Fellows Reception?Some of the most valuable conversations at LL&M Congress happen beyond th...
08/29/2026

Why attend the LL&M Congress Fellows Reception?

Some of the most valuable conversations at LL&M Congress happen beyond the educational sessions. The Fellows Reception gives hematology/oncology trainees the opportunity to:

• Connect with nationally recognized faculty
• Meet fellows from institutions across the country
• Exchange clinical perspectives and research interests
• Build relationships that may lead to mentorship and future collaboration

Join us Tuesday, October 13, at 7:00 PM at the New York Marriott Marquis.

Attendance is complimentary, but advance RSVP is requested: https://hubs.ly/Q04vNCGd0

Fellows, your future in hematologic oncology starts at  .Join trainees from across the country for expert-led education—...
08/15/2026

Fellows, your future in hematologic oncology starts at .

Join trainees from across the country for expert-led education—and opportunities to build the relationships that can shape your career.

Don’t miss the exclusive Fellows Reception, where you can:
• Connect with nationally recognized faculty
• Build relationships that can lead to mentorship and career guidance
• Meet fellows from leading institutions across the country
• Exchange clinical perspectives and research interests

LL&M Congress: October 13–16, 2026 | New York City
Fellows Reception: October 13 | 7:00 PM | New York Marriott Marquis

Register for LL&M Congress and RSVP for the complimentary Fellows Reception today. https://hubs.ly/Q04s-fG10

New data. Changing standards. More complex treatment decisions.LL&M Congress brings hematology leaders together to tackl...
08/14/2026

New data. Changing standards. More complex treatment decisions.

LL&M Congress brings hematology leaders together to tackle what’s next.
From emerging therapies to evolving clinical strategies, join four days of expert-led education focused on the questions shaping hematologic oncology today—and what they mean for your practice tomorrow.

📍 New York City | 📅 October 13–16
Join us at LL&M Congress: https://hubs.ly/Q04sjqpX0

Should every frontline Hodgkin lymphoma patient receive checkpoint inhibition—or is a more selective strategy warranted?...
08/13/2026

Should every frontline Hodgkin lymphoma patient receive checkpoint inhibition—or is a more selective strategy warranted?

It’s the kind of question where evolving evidence can have an immediate impact on clinical decision-making.

At LL&M Congress 2026, hear experts examine the data, debate evolving approaches, and translate new evidence into practical strategies for patient care.

Join the discussion:https://hubs.ly/Q04sj3Rx0

08/12/2026

Three LL&M meetings. Three distinct ways to stay connected to the evolving field of blood cancer care.

In this video, John Leonard, MD, explains how LL&M Great Debates, LL&M Congress, and LL&M Winter Symposium each serve a different purpose, from working through clinical uncertainty to exploring the field in greater depth and reviewing timely updates following the year’s major hematology meetings.

Together, they offer year-round opportunities to engage with the data, decisions, and discussions shaping hematologic malignancy care.

Learn More: https://bit.ly/4h5eay9

What comes after R-CHOP?As the treatment landscape for aggressive lymphoma continues to evolve, emerging strategies are ...
08/11/2026

What comes after R-CHOP?

As the treatment landscape for aggressive lymphoma continues to evolve, emerging strategies are challenging established approaches and creating new questions for clinical practice.

At LL&M Congress 2026, explore the latest evidence and expert perspectives shaping treatment decisions across lymphoma.

📅 October 13–16 | New York City
Explore what’s next:https://hubs.ly/Q04sj2M70

The conversations shaping the future of hematologic oncology are happening at LL&M Congress 2026. Join leading experts a...
08/10/2026

The conversations shaping the future of hematologic oncology are happening at LL&M Congress 2026. Join leading experts and your peers for four days of clinically relevant education, discussion, and perspectives designed to inform the decisions you make in practice.

📍 New York City
📅 October 13–16, 2026

Be part of the conversation. Register today: https://hubs.ly/Q04sj0Qp0

08/07/2026

Three LL&M meetings. Three distinct ways to stay connected to the evolving field of blood cancer care.

In this video, John Leonard, MD, explains how LL&M Great Debates, LL&M Congress, and LL&M Winter Symposium each serve a different purpose, from working through clinical uncertainty to exploring the field in greater depth and reviewing timely updates following the year’s major hematology meetings.

Together, they offer year-round opportunities to engage with the data, decisions, and discussions shaping hematologic malignancy care.

Learn More: https://hubs.ly/Q04sj70h0

Address

811 W 7th Avenue
New York, NY

Alerts

Be the first to know and let us send you an email when Lymphoma, Leukemia & Myeloma Congress posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share